Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects

Annals of Thoracic Surgery

Volumn 63, Issue 3, 1997, Pages 648-652

  Hiramatsu, Takeshi ^a   Imai, Yasuharu ^a   Takanashi, Yoshinori ^a   Hoshino, Shuichi ^a   Yashima, Masafumi ^a   Tanaka, Satoshi A ^a   Chang, Dehua ^a   Nakazawa, Makoto ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; NITRATE;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; FEMALE; HUMAN; LUNG BLOOD FLOW; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENDOTHELIN-1; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; NITRATES; NITRIC OXIDE; PULMONARY CIRCULATION; TIME FACTORS;

EID: 0030891192     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)01055-7     Document Type: Article

References (25)

1. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993;87(Suppl 5):36-43.
2. Yanagisawa M, Kurihara H, Tomobe Y, et al. Novel potent vasoconstrictor peptide produced by vascular endothelial cell. Nature 1988;3321:411-5.
3. Nayler WG. The endothelins. Berlin: Springer-Verlag, 1990: 1-188.
4. Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Circulation 1991;84:2280-5.
5. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993;106: 473-8.
6. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88:2128-38.
7. Shafique T, Johnson RG, Dai HB, Weintraub RM, Sellke FW. Altered pulmonary microvascular reactivity after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106: 479-86.
8. Hiramatsu T, Forbess JM, Miura T, Roth SJ, Cioffi MA, Mayer JE Jr. Effects of endothelin-1 and L-arginine after cold ischemia on recovery in lamb hearts. Ann Thorac Surg 1996; 61:36-41.
9. Brunner F, du Toit E, Opie LH. Endothelin release during ischemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 1992;24:1291-305.
10. Hynyen M, Saijonmaa O, Tickkanen I, Heinonen J, Fyhrquist F. Increased plasma endothelin immunoreactivity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992;103: 1024-5.
11. Nunez DJR, Brown MJ, Davenport AP, Neylon CB, Schofield JP, Wyse RK. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 1990;85:1537-41.
12. Goetz KL, Wang BC, Nadwed JB, Zhu JL, Leadley RJ Jr. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988;255: R1064-8.
13. Kojima T, Fukada Y, Takedatsu M, Hirata Y, Kobayashi Y. Circulating levels of endothelin and atrial natriuretic factor during postnatal life. Acta Paediatr 1992;81:676-7.
14. Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 1993;21:330-4.
15. Amezcua JL, Palmer RMJ, De Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1990;97: 1119-24.
16. McCall T, White BJR, Boughton-Smith NK, Moncada S. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol 1988;85:517P.
17. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987;90:687-92.
18. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker-Botelho LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991;181:1392-7.
19. Lopez Farre A, Riesco A, Espinosa G, et al. Effects of endothelin-1 on neutrophil adhesion to endothelial cells and perfused hearts. Circulation 1993;88:1166-71.
20. De Caterina R, Shin WS, Liao JK, Libby P. Nitric oxide inhibits cytokine-induced expression of endothelial leukocyte adhesion molecules [Abstract]. Circulation 1994;90: Pt2I-29.
21. Kubeo P, Suzuki M, Granger N. Nitric oxide: an endogenous modulation of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
22. Hiramatsu T, Forbess JM, Miura T, Mayer JE Jr. Effects of L-arginine and L-NAME on recovery of neonatal lamb hearts after cold cardioplegic ischemia: evidence for an important role for endothelial production of nitric oxide. J Thorac Cardiovasc Surg 1995;109:81-7.
23. DeNucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800.
24. Boulanger C, Lüscher TF. Release of endothelium from porcine aorta inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-90.
25. Lüscher TF, Yang Z, Tschudi M, et al. Interactions between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088-94.